Ascletis Announces China National Medical Products Administration Acceptance of New Drug Application for Denifanstat (ASC40), a First-in-Class FASN Inhibitor for Acne Treatment
-Denifanstat (ASC40) met all primary, key secondary and secondary efficacy endpoints (ITT analysis) and significantly improved moderate-to-severe acne vulgaris compared with placebo in a randomized, double-blind, placebo-controlled, multicenter...
GRADING ELEVEN AUTHENTICATION (GEA) Launches the Next Generation of Card Grading -- Bridging Art, Design, and Collectible Culture
WORLD'S FIRST INSTANT NFC-ENABLED AUTHENTICATION IN A GRADED SLAB REDEFINING COLLECTIBLE ART WITH LIMITED, UNIQUE, UV-PRINTED ARTIST-DESIGNED SLABS LEADING TURNAROUND TIMES FOR COLLECTORS ACROSS ASIA HONG KONG, Dec. 10, 2025 /PRNewswire/ -- Hong...
VisIC Technologies Announces $26M Round B Investment Led by Global Semiconductor Leader; Hyundai Motor Company and Kia (Together as "HKMC") Joins as Strategic Investor
NESS ZIONA, Israel, Dec. 10, 2025 /PRNewswire/ -- VisIC Technologies Ltd., a pioneer in Gallium Nitride (GaN) power semiconductors for electric mobility, today announced the successful second closing of its Round B funding, securing $26 million. The...
Innovent Announces First Participant Dosed in a Phase 1 Clinical Trial of IBI3011, a Recombinant Anti-Human Interleukin 1 Receptor Accessory Protein Monoclonal Antibody
SAN FRANCISCO and SUZHOU, China, Dec. 10, 2025 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of...
Autozi Internet Technology (Global) Ltd. Announces 50 for 1 Share Consolidation
BEIJING, Dec. 10, 2025 /PRNewswire/ -- Autozi Internet Technology (Global) Ltd. (Nasdaq: AZI) (the "Company" or "Autozi"), one of the leading and fast-growing lifecycle automotive service providers in China, today announced that the Company's board...
Qatar Museums' Tasweer Announces Global Photography Open Call for Under One Sky as Part of Years of Culture
DOHA, Qatar, Dec. 10, 2025 /PRNewswire/ -- As part of Years of Culture programming, Qatar Museums' Tasweer Photography initiative, in collaboration with the U.S. Department of State's Art in Embassies program, has launched an international open call...
RIDDLE 3 PTY LTD (AND OTHERS) ANNOUNCES OFFERING OF AUD 15,608,966 MEZZANINE SECURED LOAN NOTE OFFER
MELBOURNE, Australia, Dec. 9, 2025 /PRNewswire/ -- Riddle 3 Pty Ltd ACN 622 918 370 and others noted as the Issuer/Borrower in the table below (Riddle or the Issuer) is seeking to raise a total of AUD 15,608,966 in funds by the issue of loan notes,...
EpiVax and FDA Scientists Publish New Insights on Immunogenicity Risks of Peptide-Related Impurities in Generic Teriparatide
PROVIDENCE, R.I., Dec. 9, 2025 /PRNewswire/ -- EpiVax, Inc., with U.S. Food and Drug Administration (FDA) and CUBRC, Inc. (Buffalo, NY) scientist collaborators, announces the publication of a study titled "Immunogenicity Risk Assessment of...
ALR TECHNOLOGIES TO RELAUNCH THE GLUCURVE PET CGM IN JANUARY 2026
SINGAPORE, Dec. 8, 2025 /PRNewswire/ -- ALR Technologies SG Ltd ("ALRT" or the "Company") (OTC: ALRTF), the diabetes management company, announces the successful completion of internal manufacturing testing on the GluCurve Pet CGM ("GluCurve")...
Zymedi Announces "rapaprutug" as the International Nonproprietary Name (INN) for ZMA001
INCHEON, South Korea, Dec. 8, 2025 /PRNewswire/ -- Zymedi (CEO Sunghoon Kim) announced that the World Health Organization (WHO) has assigned rapaprutug as the International Nonproprietary Name (INN) for the company's first-in-class antibody therapy...